Skip to content

Chlamydia Incidence in Respiratory infeCtions sUrvey Study

Chlamydia Incidence in Respiratory infeCtions sUrvey Study - CIRCUS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55017
Enrollment
408
Registered
2021-03-04
Start date
2021-04-21
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung infection Pneumonia

Interventions

None listed

Sponsors

Zuyderland Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adult - Pneumonia defined by a new pulmonary infiltrate on chest radiograph described by the attending physician, in combination with at least two of the following criteria: cough, sputum production, temperature > 38.0 °C or 15 mg/l, and white blood cell count > 10 x 109 cells/l or 10% of rods in leukocyte differentiation. - Active sputum production

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Primary: incidence of eleven Chlamydia species in deep respiratory secretions.

Secondary

MeasureTime frame
Secondary: incidence of eleven Chlamydia species faecal samples. Tertiary: level of agreement between between deep respiratory secretions and faecal samples. comparison between animal contact between patients with our without chlamydial infection. Comparison between patient characteristics of patients with or without chlamydial infection. Comparison between clinical outcomes of patients with or without chlamydial infection.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)